Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Hypercholesterolaemia and Mixed Dyslipidaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07441317
What this trial is testing

QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 780
Post-approval studies (Phase 4)Study completedNCT06386419
What this trial is testing

A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 65
Large-scale testing (Phase 3)Ended earlyNCT03433755
What this trial is testing

Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Amgen 259
Large-scale testing (Phase 3)Study completedNCT01763866
What this trial is testing

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

Who this might be right for
Hyperlipidemia
Amgen 2,067
Large-scale testing (Phase 3)Study completedNCT05260411
What this trial is testing

Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 246
Large-scale testing (Phase 3)Study completedNCT00376584
What this trial is testing

Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)

Who this might be right for
HypercholesteremiaHyperlipidemia
Merck Sharp & Dohme LLC 825
Post-approval studies (Phase 4)Study completedNCT06925100
What this trial is testing

Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Daiichi Sankyo 180
Large-scale testing (Phase 3)Not Yet RecruitingNCT07474649
What this trial is testing

Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

Who this might be right for
Coronary AtherosclerosisMixed DyslipidemiaHypercholesterolemia
Daiichi Sankyo 103
Large-scale testing (Phase 3)Study completedNCT02189837
What this trial is testing

Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody

Who this might be right for
Primary Hyperlipidemia and Mixed Dyslipidemia
Amgen 89
Not applicableLooking for participantsNCT06686615
What this trial is testing

Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiiaMixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 2,000
Large-scale testing (Phase 3)Study completedNCT04781114
What this trial is testing

The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia

Who this might be right for
Hyperlipemia
Shanghai Junshi Bioscience Co., Ltd. 806
Large-scale testing (Phase 3)Ended earlyNCT01274559
What this trial is testing

Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,173
Large-scale testing (Phase 3)Study completedNCT00378833
What this trial is testing

Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)

Who this might be right for
HypercholesterolemiaHyperlipidemia
Merck Sharp & Dohme LLC 1,300
Large-scale testing (Phase 3)Not Yet RecruitingNCT07421284
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy

Who this might be right for
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 900
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Large-scale testing (Phase 3)Study completedNCT00479388
What this trial is testing

Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,216
Not applicableActive Not RecruitingNCT04579367
What this trial is testing

Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 5,000
Large-scale testing (Phase 3)Study completedNCT04643093
What this trial is testing

Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemias
Orient Pharma Co., Ltd. 390
Early research (Phase 1)Study completedNCT01012219
What this trial is testing

Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipidemia
Merck Sharp & Dohme LLC 36
Large-scale testing (Phase 3)Study completedNCT01879319
What this trial is testing

Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Amgen 164
Next Page